Simcor news from FiercePharma
News
Cholesterol drug market shifts
Big-name cholesterol meds are losing ground on two fronts. First, the Pfizer cholesterol drug Lipitor--its Read more...
Where Merck loses, Abbott gains
What's bad for Merck is good for Abbott Labs. When the FDA said "no" to Read more...
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets